Robert Klitzman, MD, professor of psychiatry, addresses the ethical and health concerns that must be considered in tackling the obesity epidemic and broader public health challenges.
A Columbia study shows a simple smell test and memory exam can predict cognitive decline as accurately as costly brain imaging, offering a more affordable and accessible way to assess dementia.
Dr. Sander Markx and Dr. Job de Jong are hoping their work on mini brains could lead to a pioneering study using stem cells to find and test new treatments for psychiatric disorders.
Kristina Denisova, PhD specializes in state of the art brain imaging of children at risk for Autism Spectrum Disorders (ASD) at Columbia University Irving Medical Center.
The Columbia Suicide Severity Rating Scale (C-SSRS) was primarily developed Dr. Kelly Posner as a tool to screen for suicidality in medication research trials.
“We are thrilled about our new partners and the opportunity to apply our biotechnology platform at the scale needed to identify new drugs for neuropsychiatric disorders,” said Dr. Sean Escola.
“Just being able to go to a place that doesn’t feel like therapy -- that feels like something every kid does during the summer -- that’s so important,” said Dr. Ali Mattu.
“The experts do not get this right every time. Why would we expect colleges to do so?” wrote Dr. Ravi N. Shah regarding the safety of suicidal students.